Arbutus Biopharma Corp. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
14,064.20
38,837.00
61,121.00
384,164.00
84,413.00
57,060
Depreciation, Depletion & Amortization
612.80
529.00
589.00
1,092.00
2,027.00
2,181
Other Funds
4,415.20
9,368.00
36,563.00
430,715.00
54,919.00
4,430
Funds from Operations
9,036.20
28,940.00
40,154.00
57,418.00
51,787.00
63,591
Changes in Working Capital
2,297.60
16,519.00
14,631.00
467.00
3,147.00
4,275
Net Operating Cash Flow
6,738.60
12,421.00
54,785.00
57,885.00
48,640.00
67,866
Capital Expenditures
725.10
1,056.00
2,287.00
3,996.00
7,264.00
Sale of Fixed Assets & Businesses
-
80.00
324.00
25.00
3.00
Purchase/Sale of Investments
-
41,982.00
9,645.00
95,152.00
35,086.00
Net Investing Cash Flow
725.10
42,958.00
7,682.00
99,123.00
27,825.00
Issuance/Reduction of Debt, Net
-
-
-
12,001.00
-
Net Financing Cash Flow
32,716.50
60,676.00
143,870.00
12,638.00
49,322.00
Net Change in Cash
21,692.40
3,470.00
94,592.00
143,366.00
30,879.00
Free Cash Flow
7,463.70
13,477.00
57,072.00
61,881.00
55,904.00
Deferred Taxes & Investment Tax Credit
-
-
16,185.00
105,061.00
24,320.00
4,282
Change in Capital Stock
32,716.50
60,676.00
143,870.00
637.00
49,322.00
Exchange Rate Effect
3,560.40
1,827.00
2,175.00
1,004.00
2,372.00
About Arbutus Biopharma
View Profile
